Back

ACE2 down-regulation may contribute to the increased thrombotic risk in COVID-19

European Heart Journal

20 July 2020
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE

Contributors

Laura Lupi
Laura Lupi

Author

Marianna Adamo
Marianna Adamo

Author

Civil Hospital of Brescia Brescia , Italy

Riccardo M Inciardi
Riccardo M Inciardi

Author

Civil Hospital of Brescia Brescia , Italy

Marco Metra
Marco Metra

Author

IRCCS San Raffaele Scientific Institute Milan , Italy

You may be interested in
thumbnail
Congress Presentation
Endothelial biomarkers (Von Willebrand Factor, BDCA3, Urokinase) as predictors of mortality in COVID-19 patients.
22 May 2023
thumbnail
Webinar
Cardiovascular involvement in COVID-19 patients: multimodality imaging for diagnosis, risk stratification and management
10 June 2021
thumbnail
Congress Presentation
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
1 September 2024
thumbnail
Congress Presentation
Thromboembolic events in the follow up of COVID-19 patients
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources